LYRA THERAPEUTICS INC (LYRA)
US55234L1052 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 290K | 1.36M 368.97% | 1.558M 14.56% | 1.549M -0.58% | 797.436K -48.52% | 8.118M 918.01% | 18.081M 122.73% | 37.534M 107.59% | 64.123M 70.84% | 107M 66.87% | 156.62M 46.37% | |
| EBITDA YoY % growth | -42.62M -92.76% | -53.92M -26.51% | -65.25M -21.01% | -62.74M 3.85% | -17.707M 71.78% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -43.62M -96.40% | -54.99M -26.07% | -65.528M -19.16% | -98.418M -50.19% | -59.554M 39.49% | -59.742M -0.32% | -37.014M 38.04% | -22.739M 38.57% | -36.57M -60.82% | 1.16M 103.17% | 44.92M 3,772.41% | |
| Operating Margin | -15,041.38% | -4,043.38% | -4,205.91% | -6,353.65% | -7,468.15% | -735.92% | -204.71% | -60.58% | -57.03% | 1.08% | 28.68% | |
| EPS YoY % growth | -3.35 83.42% | -1.75 47.76% | -1.25 28.57% | -1.37 -9.83% | -0.65 52.45% | -0.74 -12.89% | -0.60 18.34% | -0.22 62.71% | 0.15 168.18% | 0.38 146.67% | 0.57 51.35% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 26.75% | -0.12 66.49% | -0.11 85.53% | -0.10 46.17% | -0.11 33.54% | -0.18 -56.52% | -0.23 -119.05% | -0.32 -226.32% | -0.39 -261.90% |
| Revenue Q2Q % growth | 213.996K 46.57% | -100.00% | -100.00% | -100.00% | -100.00% | 112.2K | 112.2K | 112.2K | 1.336M |
| EBITDA Q2Q % growth | -17.136M -5.78% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.407M 18.63% | -13.26M 43.63% | -13.77M 22.66% | -12.852M -33.35% | -10.812M 19.36% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.18 33.33% | -0.23 | 0.05 | 22.60% |
| Q2 2024 Q2Q % growth | -0.74 -131.25% | -0.33 | -0.41 | -121.19% |
| Q1 2024 Q2Q % growth | -0.35 20.45% | -0.27 | -0.08 | -30.97% |
| Q4 2023 Q2Q % growth | -0.22 42.11% | -0.32 | 0.10 | 31.53% |
| Q3 2023 Q2Q % growth | -0.27 32.50% | -0.32 | 0.05 | 16.76% |
| Q2 2023 Q2Q % growth | -0.32 25.58% | -0.43 | 0.11 | 25.89% |
| Q1 2023 Q2Q % growth | -0.44 18.52% | -0.37 | -0.07 | -18.18% |
| Q4 2022 Q2Q % growth | -0.38 63.81% | -0.42 | 0.04 | 10.01% |
| Q3 2022 Q2Q % growth | -0.40 52.94% | -0.45 | 0.05 | 10.87% |
| Q2 2022 Q2Q % growth | -0.43 49.41% | -0.38 | -0.05 | -13.17% |
| Q1 2022 Q2Q % growth | -0.54 10.00% | -0.93 | 0.39 | 42.14% |
| Q4 2021 Q2Q % growth | -1.05 -128.26% | -0.81 | -0.24 | -30.31% |
| Q3 2021 Q2Q % growth | -0.85 -73.47% | -0.75 | -0.10 | -13.38% |
| Q2 2021 Q2Q % growth | -0.85 -51.79% | -0.61 | -0.24 | -40.45% |
| Q1 2021 Q2Q % growth | -0.60 96.79% | -0.49 | -0.11 | -22.55% |
| Q4 2020 Q2Q % growth | -0.46 | -0.57 | 0.11 | 19.47% |
| Q3 2020 Q2Q % growth | -0.49 | -0.41 | -0.08 | -18.13% |
| Q2 2020 Q2Q % growth | -0.56 | -0.38 | -0.18 | -45.76% |
| Q1 2020 Q2Q % growth | -18.70 | -0.68 | -18.02 | -2,636.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 195K -64.15% | 326.4K | -131.4K | -40.26% |
| Q2 2024 Q2Q % growth | 598K 30.57% | 356.796K | 241.204K | 67.60% |
| Q1 2024 Q2Q % growth | 532K 29.76% | 428.4K | 103.6K | 24.18% |
| Q4 2023 Q2Q % growth | 146K 1,360.00% | 396.576K | -250.576K | -63.18% |
| Q3 2023 Q2Q % growth | 544K 51.11% | 379.032K | 164.968K | 43.52% |
| Q2 2023 Q2Q % growth | 458K -13.58% | 139.403K | 318.597K | 228.54% |
| Q1 2023 Q2Q % growth | 410K -12.77% | 162.69K | 247.31K | 152.01% |
| Q4 2022 Q2Q % growth | 10K -96.30% | 154.836K | -144.836K | -93.54% |
| Q3 2022 Q2Q % growth | 360K 3,500.00% | 138.383K | 221.617K | 160.15% |
| Q2 2022 Q2Q % growth | 530K | 1.471M | -941K | -63.97% |
| Q1 2022 Q2Q % growth | 470K | 1.275M | -805K | -63.14% |
| Q4 2021 Q2Q % growth | 270K | 1.173M | -903K | -76.98% |
| Q3 2021 Q2Q % growth | 10K | 408K | -398K | -97.55% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 44.37% | -1.05% | -1.05% |
| Revenue | 0.48% | -42.68% | -12.78% | -12.78% |